vs

Side-by-side financial comparison of Instil Bio, Inc. (TIL) and Twin Vee PowerCats, Co. (VEEE). Click either name above to swap in a different company.

Twin Vee PowerCats, Co. is the larger business by last-quarter revenue ($3.0M vs $2.2M, roughly 1.3× Instil Bio, Inc.). Twin Vee PowerCats, Co. runs the higher net margin — -85.6% vs -365.3%, a 279.7% gap on every dollar of revenue. On growth, Twin Vee PowerCats, Co. posted the faster year-over-year revenue change (60.4% vs -19.2%).

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

Twin Vee PowerCats Co. is a leading manufacturer of high-performance recreational power catamaran boats. The company offers a diverse lineup of catamaran models suited for leisure cruising, fishing, water sports, and commercial marine use, serving customers primarily across North America, with a growing distribution network in global coastal markets.

TIL vs VEEE — Head-to-Head

Bigger by revenue
VEEE
VEEE
1.3× larger
VEEE
$3.0M
$2.2M
TIL
Growing faster (revenue YoY)
VEEE
VEEE
+79.6% gap
VEEE
60.4%
-19.2%
TIL
Higher net margin
VEEE
VEEE
279.7% more per $
VEEE
-85.6%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TIL
TIL
VEEE
VEEE
Revenue
$2.2M
$3.0M
Net Profit
$-8.2M
$-2.6M
Gross Margin
3.7%
Operating Margin
-426.3%
-87.7%
Net Margin
-365.3%
-85.6%
Revenue YoY
-19.2%
60.4%
Net Profit YoY
31.1%
-119.0%
EPS (diluted)
$-1.13
$-1.19

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TIL
TIL
VEEE
VEEE
Q4 25
$2.2M
$3.0M
Q3 25
$2.2M
$3.4M
Q2 25
$2.2M
$4.8M
Q1 25
$2.2M
$3.6M
Q4 24
$2.8M
$1.9M
Q3 24
$1.5M
$2.9M
Q2 24
$0
$4.3M
Q1 24
$0
$5.3M
Net Profit
TIL
TIL
VEEE
VEEE
Q4 25
$-8.2M
$-2.6M
Q3 25
$-13.6M
$-2.8M
Q2 25
$-21.4M
$-1.7M
Q1 25
$-28.2M
$-1.6M
Q4 24
$-11.9M
$-1.2M
Q3 24
$-23.0M
$-3.0M
Q2 24
$-14.9M
$-4.5M
Q1 24
$-24.3M
$-2.3M
Gross Margin
TIL
TIL
VEEE
VEEE
Q4 25
3.7%
Q3 25
-1.3%
Q2 25
13.8%
Q1 25
14.9%
Q4 24
-57.6%
Q3 24
-5.0%
Q2 24
4.7%
Q1 24
5.3%
Operating Margin
TIL
TIL
VEEE
VEEE
Q4 25
-426.3%
-87.7%
Q3 25
-670.0%
-81.0%
Q2 25
-1045.5%
-35.2%
Q1 25
-1363.2%
-46.5%
Q4 24
-426.1%
-224.9%
Q3 24
-1582.8%
-107.3%
Q2 24
-107.7%
Q1 24
-48.2%
Net Margin
TIL
TIL
VEEE
VEEE
Q4 25
-365.3%
-85.6%
Q3 25
-606.0%
-80.4%
Q2 25
-954.2%
-34.8%
Q1 25
-1257.8%
-44.6%
Q4 24
-428.8%
-62.7%
Q3 24
-1541.9%
-103.7%
Q2 24
-104.4%
Q1 24
-44.3%
EPS (diluted)
TIL
TIL
VEEE
VEEE
Q4 25
$-1.13
$-1.19
Q3 25
$-2.01
$-1.23
Q2 25
$-3.24
$-0.87
Q1 25
$-4.32
$-1.08
Q4 24
$-1.82
$-3.51
Q3 24
$-3.54
$-2.64
Q2 24
$-2.29
$-3.09
Q1 24
$-3.74
$-1.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TIL
TIL
VEEE
VEEE
Cash + ST InvestmentsLiquidity on hand
$6.6M
$1.4M
Total DebtLower is stronger
$499.9K
Stockholders' EquityBook value
$113.9M
$13.5M
Total Assets
$203.5M
$16.2M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TIL
TIL
VEEE
VEEE
Q4 25
$6.6M
$1.4M
Q3 25
$5.8M
$2.7M
Q2 25
$7.7M
$6.0M
Q1 25
$15.4M
$4.9M
Q4 24
$8.8M
$7.5M
Q3 24
$6.7M
$11.1M
Q2 24
$6.8M
$14.9M
Q1 24
$5.5M
$17.1M
Total Debt
TIL
TIL
VEEE
VEEE
Q4 25
$499.9K
Q3 25
$499.9K
Q2 25
$499.9K
Q1 25
$499.9K
Q4 24
$499.9K
Q3 24
$499.9K
Q2 24
$499.9K
Q1 24
$499.9K
Stockholders' Equity
TIL
TIL
VEEE
VEEE
Q4 25
$113.9M
$13.5M
Q3 25
$120.4M
$15.9M
Q2 25
$131.7M
$18.6M
Q1 25
$144.9M
$17.7M
Q4 24
$169.4M
$19.2M
Q3 24
$176.3M
$17.4M
Q2 24
$195.0M
$19.6M
Q1 24
$205.8M
$22.3M
Total Assets
TIL
TIL
VEEE
VEEE
Q4 25
$203.5M
$16.2M
Q3 25
$211.8M
$18.9M
Q2 25
$231.0M
$22.4M
Q1 25
$237.4M
$23.6M
Q4 24
$263.6M
$25.9M
Q3 24
$272.6M
$30.1M
Q2 24
$294.3M
$33.8M
Q1 24
$306.3M
$36.5M
Debt / Equity
TIL
TIL
VEEE
VEEE
Q4 25
0.04×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TIL
TIL
VEEE
VEEE
Operating Cash FlowLast quarter
$-7.1M
$-1.7M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-62.5%
Capex IntensityCapex / Revenue
4.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-9.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TIL
TIL
VEEE
VEEE
Q4 25
$-7.1M
$-1.7M
Q3 25
$-10.6M
$-2.6M
Q2 25
$-14.8M
$-745.6K
Q1 25
$-4.2M
$-1.7M
Q4 24
$-10.6M
$-2.3M
Q3 24
$-20.1M
$-2.4M
Q2 24
$-10.6M
$-482.1K
Q1 24
$-14.4M
$-1.7M
Free Cash Flow
TIL
TIL
VEEE
VEEE
Q4 25
$-1.9M
Q3 25
$-3.1M
Q2 25
$-1.5M
Q1 25
$-2.6M
Q4 24
$-3.6M
Q3 24
$-3.7M
Q2 24
$-2.2M
Q1 24
$-3.7M
FCF Margin
TIL
TIL
VEEE
VEEE
Q4 25
-62.5%
Q3 25
-91.2%
Q2 25
-30.6%
Q1 25
-71.0%
Q4 24
-192.8%
Q3 24
-128.8%
Q2 24
-51.0%
Q1 24
-70.9%
Capex Intensity
TIL
TIL
VEEE
VEEE
Q4 25
4.6%
Q3 25
14.0%
Q2 25
14.9%
Q1 25
22.9%
Q4 24
0.0%
68.8%
Q3 24
0.0%
45.8%
Q2 24
39.9%
Q1 24
37.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons